GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.
The UK drugmaker is scheduled to begin shipping Alli to US pharmacies today, with the weight loss remedy expected to officially go on sale next Monday.
Early demand from retailers has been strong from retailers, including Wal-Mart Stores, and 400,000 Alli starter kits are being shipped to fill the supply chain.
Analysts estimate the launch of Alli will be one of the biggest ever for an OTC medicine. GlaxoSmithKline is spending an estimated $150 million on marketing in the US.
Alli will retail for between $55 and $60 for a month’s supply, based on a regimen of three pills a day.
Citigroup estimates global Alli sales could hit $724 million by 2011.